Transgene expression of human PON1 Q in mice protected the liver against CCl4-induced injury

Journal of Gene Medicine

Volumn 10, Issue 1, 2008, Pages 94-100

  Zhang, Chi ^a   Peng, Wei ^a   Jiang, Xiaoling ^a   Chen, Bo ^a   Zhu, Jie ^a   Zang, Yuhui ^a   Zhang, Junfeng ^a   Zhu, Tongyang ^a   Qin, Junchuan ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Gene transfer; Human paraoxonase 1 Q; Liver injury; Oxidative stress; Skeletal muscle

Indexed keywords

ALANINE AMINOTRANSFERASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 1 Q; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; MALONALDEHYDE; MESSENGER RNA; PLASMID DNA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPORATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE LOCATION; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; MOLECULAR CLONING; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; TRANSGENE;

ALANINE TRANSAMINASE; ANIMALS; ARYLDIALKYLPHOSPHATASE; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LIVER DISEASES; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; MUSCLE FIBERS; MUSCLE, SKELETAL; PLASMIDS; TRANSGENES;

MUS;

EID: 38349110457     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1128     Document Type: Article

References (27)

1. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250.
2. Friedman SL, Maher JJ, Bissell DM. Mechanisms and therapy of hepatic fibrosis: report of the AASLD single topic basic research conference. Hepatology 2000; 32: 1403-1408.
3. Pinzani M, Gentilini P. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Semin Liver Dis 1999; 19: 397-410.
4. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J Hepatol 1998; 28(Suppl 1): 8-13.
5. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radical Biol Med 1997; 22: 287-305.
6. Parola M, Bellomo G, Robino G, et al. 4-Hydroxynonenal as a biological signal: molecular bases and pathophysiological implications. Antioxidant Redox Signaling 1999; 1: 255-284.
7. Richard WJ, Sara PD. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radical Biol Med 2004; 37: 1986-1994.
8. Aviram M. Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. Free Radical Biol Med 2004; 37: 1301-1303.
9. Zhu J, Ze Y, Zhang C, et al. High level expression of recombinant human paraoxonasel Q in silkworm larvae (Bombyx mori). Appl Microbiol Biotechnol 2006; 72: 103-108.
10. Li H, Liu D, Liang C. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 2003; 81: 766-769.
11. Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biol Med 1999; 26: 892-904.
12. Ferre N, Camps J, Prats E, et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem 2002; 48: 261-268.
13. Ferre N, Marsillach J, Camps J, et al. Paraoxonasp-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J Hepatol 2006; 45: 51 -59.
14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
15. Lee KJ, Woo ER, Choi CY, et al. Protective effect of acteoside on carbon tetrachloride-induced hepatotoxicity. Life Sci 2004; 74: 1051-1064.
16. Ferre N, Camps J, Cabre M, et al. Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. Metabolism 2001; 9: 997-1000.
17. Demirdag K, Bahcecioglu IH, Ozercan IH, et al. Role of L-carnitine in the prevention of acute liver damage induced by carbon tetrachloride in rats. J Gastroentrol Hepatol 2004; 19: 333-338.
18. Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 2005; 7: 992-1009.
19. White RE, Wade-Martins R, Hart SL, et al. Functional delivery of large genomic DNA to human cells with a peptide-lipid vector. J Gene Med 2003; 5: 883-892.
20. Wells DJ. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004; 11: 1363-1369.
21. Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-447.
22. McMahon JM, Wells DJ. Electroporation for gene transfer to skeletal Muscles. Biodrugs 2004; 18: 155-165.
23. Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262-4267.
24. Mir LM, Bureau MF, Rangara R, et al. High level in vivo gene expression after electric pulsernediated gene transfer into skeletal muscle. C R. Acad. Sci. III 1998; 321: 893-899.
25. McMahon JM, Signori E, Wells KE, et al. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase-increased expression with reduced muscle damage. Gene Ther 2001; 8: 1264-1270.
26. Wong SH, Lowes KN, Quigley AF, et al. DNA electroporation in vivo targets mature fibres in dystrophic mdx muscle. FEBS Lett 2001; 495: 16-20.
27. Dong Y, Tang JG. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA nto skeletal muscle in vivo. FEBS Lett 2001; 495: 16-20.